🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 6 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/04/1996 | 28,27 | 28,45 | 27,37 | 28,33 | +1,06% | 3,80% | 13.724.818 |
| 10/04/1996 | 29,04 | 29,34 | 27,85 | 28,03 | -3,89% | 5,13% | 11.058.915 |
| 09/04/1996 | 29,88 | 29,88 | 29,10 | 29,16 | -1,21% | 2,59% | 5.783.493 |
| 08/04/1996 | 29,70 | 29,88 | 28,98 | 29,52 | -3,13% | 3,01% | 9.252.163 |
| 04/04/1996 | 30,42 | 30,71 | 30,42 | 30,47 | +0,59% | 0,98% | 4.595.270 |
| 03/04/1996 | 30,36 | 30,77 | 30,18 | 30,30 | +0,00% | 1,96% | 5.747.022 |
| 02/04/1996 | 30,47 | 30,47 | 30,06 | 30,30 | +0,20% | 1,37% | 4.303.507 |
| 01/04/1996 | 29,82 | 30,30 | 29,76 | 30,24 | +1,81% | 1,80% | 6.241.050 |
| 29/03/1996 | 30,24 | 30,30 | 29,70 | 29,70 | -1,19% | 1,97% | 4.060.371 |
| 28/03/1996 | 30,00 | 30,30 | 29,88 | 30,06 | -0,20% | 1,39% | 4.450.856 |
| 27/03/1996 | 31,13 | 31,13 | 29,94 | 30,12 | -1,56% | 3,83% | 6.448.763 |
| 26/03/1996 | 29,76 | 30,65 | 29,64 | 30,59 | +2,60% | 3,41% | 7.631.536 |
| 25/03/1996 | 29,34 | 30,30 | 29,22 | 29,82 | -1,57% | 3,66% | 9.770.714 |
| 22/03/1996 | 31,37 | 31,37 | 30,30 | 30,30 | -3,05% | 3,42% | 7.433.883 |
| 21/03/1996 | 30,30 | 31,31 | 30,30 | 31,25 | +3,97% | 3,35% | 8.477.062 |
| 20/03/1996 | 29,82 | 30,30 | 29,76 | 30,06 | +1,41% | 1,80% | 8.371.843 |
| 19/03/1996 | 30,12 | 30,42 | 29,58 | 29,64 | -1,00% | 2,77% | 9.560.904 |
| 18/03/1996 | 30,06 | 30,18 | 29,76 | 29,94 | +1,01% | 1,39% | 7.271.024 |
| 15/03/1996 | 29,58 | 30,00 | 29,34 | 29,64 | +0,20% | 2,22% | 11.562.794 |
| 14/03/1996 | 29,58 | 30,36 | 29,52 | 29,58 | +0,61% | 2,82% | 11.207.731 |
| 13/03/1996 | 30,18 | 30,47 | 29,22 | 29,40 | -2,38% | 4,15% | 9.498.024 |
| 12/03/1996 | 30,71 | 30,77 | 29,82 | 30,12 | -2,70% | 3,11% | 8.511.227 |
| 11/03/1996 | 30,53 | 31,13 | 30,24 | 30,95 | +6,35% | 2,93% | 8.681.422 |
| 08/03/1996 | 31,67 | 31,67 | 28,63 | 29,10 | -8,95% | 9,60% | 12.306.245 |
| 07/03/1996 | 31,85 | 32,14 | 31,73 | 31,97 | +1,13% | 1,31% | 4.963.957 |
| 06/03/1996 | 32,44 | 32,62 | 31,55 | 31,61 | -3,81% | 3,31% | 4.870.266 |
| 05/03/1996 | 32,56 | 32,92 | 32,32 | 32,86 | +0,73% | 1,83% | 3.421.930 |
| 04/03/1996 | 32,32 | 32,74 | 32,20 | 32,62 | +1,48% | 1,66% | 4.977.581 |
| 01/03/1996 | 31,97 | 32,14 | 31,49 | 32,14 | +1,70% | 2,05% | 6.137.088 |
| 29/02/1996 | 31,31 | 32,08 | 31,25 | 31,61 | +0,57% | 2,67% | 6.076.514 |